Omega 6 fatty acids for the primary prevention of cardiovascular disease

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 11, 2015, Pages

  Al Khudairy, Lena ^a   Hartley, Louise ^a   Clar, Christine ^b   Flowers, Nadine ^a   Hooper, Lee ^c   Rees, Karen ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b Norwich Medical School ^*  (Germany)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CHOLESTEROL; DIHOMO GAMMA LINOLENIC ACID; GAMMA LINOLENIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; OMEGA 6 FATTY ACID;

ALL CAUSE MORTALITY; ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY BYPASS GRAFT; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ADULT; AGED; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; MALE; MIDDLE AGED; PROCEDURES;

ADULT; AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRIGLYCERIDES;

EID: 84980324097     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011094.pub2     Document Type: Review

References (182)

1. Moore CS, Bryant SP, Mishra GD, Krebs JD, Browning LM, Miller GJ, et al. Oily fish reduces plasma triaclyglycerols: a primary prevention study in overweight men and women. Nutrition 2006;22(10):1012-24.
2. Moore CS, Bryant SP, Mishra GD, Krebs JD, Browning LM, Miller GJ, et al. Oily fish reduces plasma triaclyglycerols: a primary prevention study in overweight men and women. Nutrition 2006;22(10):1012-24.
3. Griffin MD, Sanders TA, Davies IG, Morgan LM, Millward DJ, Lewis F, et al. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. American Journal of Clinical Nutrition 2006;84(6):1290-8.
4. Sanders TAB, Lewis F, Slaughter S, Griffin BA, Griffin M, Davies I, et al. Effect of varying the ratio of n-6 to n-3 fatty acids by increasing the dietary intake of alpha-linolenic acid, eicosapentaenoic and docosahexaenoic acid, or both on fibrinogen and clotting factors VII and XII in persons aged 45-70 y: the OPTILIP study. American Journal of Clinical Nutrition 2006;84(3):513-22.
5. Sarkkinen ES, Uusitupa MI, Gylling H, Miettinen TA. Fat-modified diets influence serum concentrations of cholesterol precursors and plant sterols in hypercholesterolemic subjects. Metabolism 1998;47(6):744-50.
6. Sluijs I, Plantinga Y, de Roos B, Mennen LI, Bots ML. Dietary supplementation with cis-9, trans-11 conjugated linoleic acid and aortic stiffness in overweight and obese adults. American Journal of Clinical Nutrition 2010;91(1):175-83.
7. Ahrén B, Mari A, Fyfe CL, Tsofliou F, Sneddon AA, Wahle KW, et al. Effects of conjugated linoleic acid plus n-3 polyunsaturated fatty acids on insulin secretion and estimated insulin sensitivity in men. European Journal of Clinical Nutrition 2009;63(6):778-86.
8. Allman-Farinelli MA, Hall D, Kingham K, Pang D, Petocz P, Favaloro EJ. Comparison of the effects of two low fat diets with different alpha-linolenic:linoleic acid ratios on coagulation and fibrinolysis. Atherosclerosis 1999;142(1):159-68.
9. Anderson JT, Grande F, Keys A. Essential fatty acids, degree of unsaturation, and effect of corn (maize) oil on the serum-cholesterol level in man. Lancet 1957;272(6959):66-8.
10. Angela Liou Y, Innis SM. Dietary linoleic acid has no effect on arachidonic acid, but increases n-6 eicosadienoic acid, and lowers dihomo--linolenic and eicosapentaenoic acid in plasma of adult men. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2009;80(4):201-6.
11. Bachmair EM, Bots ML, Mennen LI, Kelder T, Evelo CT, Horgan GW, et al. Effect of supplementation with an 80:20 cis9, trans11 conjugated linoleic acid blend on the human platelet proteome. Molecular Nutrition & Food Research 2012;56(7):1148-59.
12. Becker N, Illingworth DR, Alaupovic P, Connor WE, Sundberg EE. Effects of saturated, monounsaturated, and omega-6 polyunsaturated fatty acids on plasma lipids, lipoproteins, and apoproteins in humans. American Journal of Clinical Nutrition 1983;37(3):355-60.
13. Belury M, Collene A, Norris L, Asp M, Hsu J, Li D, et al. Comparison of dietary oils on criteria of metabolic syndrome in postmenopausal women: a randomized crossover clinical intervention study. Journal of Diabetes 2009;1:A34.
14. Bemelmans WJ, Muskiet FA, Feskens EJ, de Vries JH, Broer J, May JF, et al. Associations of alpha-linolenic acid and linoleic acid with risk factors for coronary heart disease. European Journal of Clinical Nutrition 2000;54(12):865-71.
15. Bemelmans WJ, Lefrandt JD, Feskens EJ, van Haelst PL, Broer J, Meyboom-de Jong B, et al. Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis. European Journal of Clinical Nutrition 2004;58(7):1083-9.
16. Benito P, Nelson GJ, Kelley DS, Bartolini G, Schmidt PC, Simon V. The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. [Erratum appears in Lipids 2001 Aug;36(8):857]. Lipids 2001;36(3):229-36.
17. Bermejo LM, Rodriguez-Duran D, Lopez-Plaza B, Zurita-Rosa L, Palma-Milla S, Weber TK, et al. Effects of a functional light cheese naturally enriched with CLA and omega-3 improving blood lipid profile in overweight and obese people treatment. Clinical Nutrition, Supplement 2012;7(1):219.
18. Bjermo H, Iggman D, Kullberg J, Dahlman I, Johansson L, Persson L, et al. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. American Journal of Clinical Nutrition 2012;95(5):1003-12.
19. Blair IA, Prakash C, Phillips MA, Dougherty RM, Iacono JM. Dietary modification of omega 6 fatty acid intake and its effect on urinary eicosanoid excretion. American Journal of Clinical Nutrition 1993;57(2):154-60.
20. Boberg M, Vessby B, Selinus I. Effects of dietary supplementation with n-6 and n-3 long-chain polyunsaturated fatty acids on serum lipoproteins and platelet function in hypertriglyceridaemic patients. Acta Medica Scandinavica 1986;220(2):153-60.
21. Bonanome A, Pagnan A, Biffanti S, Opportuno A, Sorgato F, Dorella M, et al. Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification. Arteriosclerosis and Thrombosis 1992;12(4):529-33.
22. Bouwens M, van De Rest O, Dellschaft N, Bromhaar MG, De Groot LC, Geleijnse JM, et al. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. American Journal of Clinical Nutrition 2009;90(2):415-24.
23. Brady LM, Lovegrove SS, Lesauvage SV, Gower BA, Minihane AM, Williams CM, et al. Increased n-6 polyunsaturated fatty acids do not attenuate the effects of long-chain n-3 polyunsaturated fatty acids on insulin sensitivity or triacylglycerol reduction in Indian Asians. American Journal of Clinical Nutrition 2004;79(6):983-91.
24. Bramkamp K, Wirths W. Influence of linoleic acid enriched margarine on serum cholesterol levels in the elderly [Über den Einfluß von linolsäurereicher Margarine auf den Serumcholesterinspiegel älterer Menschen]. Zeitschrift für Ernährungswissenschaft 1974;13(1-2):59-68.
25. Bronsgeest-Schoute DC, Hermus RJ, Dallinga-Thie GM, Hautvast JG. Dependence of the effects of dietary cholesterol and experimental conditions on serum lipids in man. II. Effects of dietary cholesterol in a linoleic acid-poor diet. American Journal of Clinical Nutrition 1979;32(11):2188-92.
26. Brox JH, Killie JE, Gunnes S, Nordøy A. The effect of cod liver oil and corn oil on platelets and vessel wall in man. Thrombosis and Haemostasis 1981;46(3):604-11.
27. Burdge GC, Lupoli B, Russell JJ, Tricon S, Kew S, Banerjee T, et al. Incorporation of cis-9, trans-11 or trans-10, cis-12 conjugated linoleic acid into plasma and cellular lipids in healthy men. Journal of Lipid Research 2004;45(4):736-41.
28. Camargo A, Meneses M, Rangel-Zuniga, O, Pérez-Martínez P, Delgado-Lista J, Marín C, et al. Dietary fat modifies lipid metabolism in the adipose tissue of patients with metabolic syndrome. Annals of Nutrition and Metabolism 2013;62:63.
29. Carvalho RF, Uehara SK, Rosa G. Microencapsulated conjugated linoleic acid associated with hypocaloric diet reduces body fat in sedentary women with metabolic syndrome. Vascular Health and Risk Management 2012;8:661-7.
30. Cater NB, Heller HJ, Denke MA. Comparison of the effects of medium-chain triacylglycerols, palm oil, and high oleic acid sunflower oil on plasma triacylglycerol fatty acids and lipid and lipoprotein concentrations in humans. American Journal of Clinical Nutrition 1997;65(1):41-5.
31. Clandinin MT, Cook SL, Konrad SD, Goh YK, French MA. The effect of palmitic acid on lipoprotein cholesterol levels and endogenous cholesterol synthesis in hyperlipidemic subjects. Lipids 1999;34 Suppl:S121-4.
32. Dayton S, Pearce ML, Hashimoto S, Fakler LJ, Hiscock E, Dixon WJ. A controlled clinical trial of a diet high in unsaturated fat. Preliminary observations. New England Journal of Medicine 1962;266:1017-23.
33. Deferne JL, Leeds AR. The antihypertensive effect of dietary supplementation with a 6-desaturated essential fatty acid concentrate as compared with sunflower seed oil. Journal of Human Hypertension 1992;6(2):113-9.
34. de Kok TM, Zwingman I, Moonen EJ, Schilderman PA, Rhijnsburger E, Haenen GR, et al. Analysis of oxidative DNA damage after human dietary supplementation with linoleic acid. Food and Chemical Toxicology 2003;41(3):351-8.
35. Dembinska-Kiec A, Malczewska-Malec M, Roche H, Leszczynska-Golabek I, Hartwich J, Wybranska I, et al. The effect of the n-3/n-6 PUFA ratio on the transformation of postprandial state proatherogenic LDL phenotype and oxidative stress parameters. Atherosclerosis Supplements. 2010; Vol. 11, issue 2:129-30.
36. Dembinska-Kiec A, Malczewska-Malec M, Hartwich J, Wnek D, Goralska J, Kiec-Wilk B, et al. The effect of dietary intervention on proatherogenic profile of lipoproteins and the blood oxidative stress parameters measured in the course of postprandial lipemia: Lipgene study. Journal of Diabetes 2011;3(s1):28.
37. Elisha B, Guebre-Egziabher F, Vidal H, Bastard J, Laville M, Rabasa-Lhoret R. From French to Mediterranean Diet: importance of the omega-6/omega-3 fatty acids ratio. World Review of Nutrition and Dietetics 2011;102:81-91.
38. Failor RA, Childs MT, Bierman EL. The effects of omega 3 and omega 6 fatty acid-enriched diets on plasma lipoproteins and apoproteins in familial combined hyperlipidemia. Metabolism: Clinical and Experimental 1988;37(11):1021-8.
39. Finnegan YE, Howarth D, Minihane AM, Kew S, Miller GJ, Calder PC, et al. Plant and marine derived (n-3) polyunsaturated fatty acids do not affect blood coagulation and fibrinolytic factors in moderately hyperlipidemic humans. Journal of Nutrition 2003;133(7):2210-3.
40. Finnegan YE, Minihane AM, Leigh-Firbank EC, Kew S, Meijer GW, Muggli R, et al. Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. American Journal of Clinical Nutrition 2003;77(4):783-95.
41. Friday KE, Failor RA, Childs MT, Bierman EL. Effects of n-3 and n-6 fatty acid-enriched diets on plasma lipoproteins and apolipoproteins in heterozygous familial hypercholesterolemia. Arteriosclerosis and Thrombosis 1991;11(1):47-54.
42. Gaullier JM, Halse J, Høye K, Kristiansen K, Fagertun H, Vik H, et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. American Journal of Clinical Nutrition 2004;79(6):1118-25.
43. Gaullier JM, Halse J, Høye K, Kristiansen K, Fagertun H, Vik H, et al. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. Journal of Nutrition 2005;135(4):778-84.
44. Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, et al. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal of Nutrition 2007;97(3):550-60.
45. Ghafoorunissa, Reddy V, Sesikaran B. Palmolein and groundnut oil have comparable effects on blood lipids and platelet aggregation in healthy Indian subjects. Lipids 1995;30(12):1163-9.
46. Ghafoorunissa, Vani A, Laxmi R, Sesikeran B. Effects of dietary alpha-linolenic acid from blended oils on biochemical indices of coronary heart disease in Indians. Lipids 2002;37(11):1077-86.
47. Giacco R, Cuomo V, Vessby B, Uusitupa M, Hermansen K, Meyer BJ, et al. Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 2007;17(8):572-80.
48. Groen JJ, Balogh M, Yaron E, Freeman J. Influence of the nature of the fat in diets high in carbohydrate (mainly derived from bread) on the serum cholesterol. American Journal of Clinical Nutrition 1965;17(5):296-304.
49. Grundt H, Nilsen D, Hetland O, Aarsland T, Baksaas I, Grande T, et al. Improvement of serum lipids and blood pressure during intervention with n-3 fatty acids was not associated with changes in insulin levels in subjects with combined hyperlipidaemia. Journal of Internal Medicine 1995;237:249-59.
50. Grønn M, Gørbitz C, Christensen E, Levorsen A, Ose L, Hagve TA, et al. Dietary n-6 fatty acids inhibit the incorporation of dietary n-3 fatty acids in thrombocyte and serum phospholipids in humans: a controlled dietetic study. Scandinavian Journal of Clinical and Laboratory Investigation 1991;51(3):255-63.
51. Haglund O, Wallin R, Wretling S, Hultberg B, Saldeen T. Effects of fish oil alone and combined with long chain (n-6) fatty acids on some coronary risk factors in male subjects. Journal of Nutritional Biochemistry 1998;9(11):629-35.
52. Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ, et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009;119(6):902-7.
53. Hartwich J, Malczewska-Malec M, Kiec-Wilk B, Leszczynska-Golabek I, Dembinska-Kiec A, Pérez-Martinez P, et al. The effect of the N-3/N-6 pufa ratio on the postprandial LDL phenotype and ischemia modified albumin (IMA). The LIPGENE study. Atherosclerosis Supplements. 2009; Vol. 10, issue 2.
54. Hartwich J, Leszczynska-Golabek I, Kiec-Wilk B, Siedlecka D, Pérez-Martinez P, Marin C, et al. Lipoprotein profile, plasma ischemia modified albumin and LDL density change in the course of postprandial lipemia. Insights from the LIPGENE study. Scandinavian Journal of Clinical and Laboratory Investigation 2010;70(3):201-8.
55. Heine RJ, Mulder C, Popp-Snijders C, van der Meer J, van der Veen EA. Linoleic-acid-enriched diet: long-term effects on serum lipoprotein and apolipoprotein concentrations and insulin sensitivity in noninsulin-dependent diabetic patients. American Journal of Clinical Nutrition 1989;49(3):448-56.
56. Higdon JV, Liu J, Du SH, Morrow JD, Ames BN, Wander RC. Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F(2)-isoprostanes. American Journal of Clinical Nutrition 2000;72(3):714-22.
57. Higdon JV, Du SH, Lee YS, Wu T, Wander RC. Supplementation of postmenopausal women with fish oil does not increase overall oxidation of LDL ex vivo compared to dietary oils rich in oleate and linoleate. Journal of Lipid Research 2001;42(3):407-18.
58. Ho M, Maple C, Bancroft A, McLaren M, Belch JJ. The beneficial effects of omega-3 and omega-6 essential fatty acid supplementation on red blood cell rheology. Prostaglandins, Leukotrienes, and Essential Fatty Acids 1999;61(1):13-7.
59. Hodson L, Skeaff CM, Chisholm WA. The effect of replacing dietary saturated fat with polyunsaturated or monounsaturated fat on plasma lipids in free-living young adults. European Journal of Clinical Nutrition 2001;55(10):908-15.
60. Hui R, St-Louis J, Falardeau P. Anti-hypertensive properties of linoleic acid and fish oil omega-3 fatty acids independant of the prostaglandin system. American Journal of Hypertension 1989;2(8):610-7.
61. Hwang DH, Chanmugam PS, Ryan DH, Boudreau MD, Windhauser MM, Tulley RT, et al. Does vegetable oil attenuate the beneficial effects of fish oil in reducing risk factors for cardiovascular disease?. American Journal of Clinical Nutrition 1997;66(1):89-96.
62. Intorre F, Venneria E, Finotti E, Foddai MS, Toti E, Catasta G, et al. Fatty acid content of serum lipid fractions and blood lipids in normolipidaemic volunteers fed two types of cheese having different fat compositions: a pilot study. International Journal of Food Sciences and Nutrition 2013;64(2):185-93.
63. Iwata T, Kamegai T, Yamauchi-Sato Y, Ogawa A, Kasai M, Aoyama T, et al. Safety of dietary conjugated linoleic acid (CLA) in a 12-weeks trial in healthy overweight Japanese male volunteers. Journal of Oleo Science 2007;56(10):517-25.
64. Khan F, Elherik K, Bolton-Smith C, Barr R, Hill A, Murrie I, et al. The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects. Cardiovascular Research 2003;59(4):955-62.
65. Kiecolt-Glaser JK, Epel ES, Belury MA, Andridge R, Lin J, Glaser R, et al. Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial. Brain, Behavior, and Immunity 2013;28:16-24.
66. Kim JH, Kim OH, Jung H. Effects of supplementation of conjugated linoleic acid with gammaoryzanol on body fat mass in healthy overweight Korean women. FASEB Journal. 2009; Vol. 23 (Meeting Abstract Supplement), issue 1:563.26.
67. Kingsbury KJ, Aylott C, Morgan DM, Emmerson R. Effects of ethyl arachidonate, cod-liver oil, and corn oil on the plasma-cholesterol level. A comparison in normal volunteers. Lancet 1961;1(7180):739-41.
68. Knapp HR, FitzGerald GA. The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. New England Journal of Medicine 1989;320(16):1037-43.
69. Koyama N, Suzuki K, Furukawa Y, Arisaka H, Seki T, Kuribayashi K, et al. Effects of safflower seed extract supplementation on oxidation and cardiovascular risk markers in healthy human volunteers. British Journal of Nutrition 2009;101(4):568-75.
70. Lambert EV, Goedecke JH, Bluett K, Heggie K, Claassen A, Rae DE, et al. Conjugated linoleic acid versus high-oleic acid sunflower oil: effects on energy metabolism, glucose tolerance, blood lipids, appetite and body composition in regularly exercising individuals. British Journal of Nutrition 2007;97(5):1001-11.
71. Lands WE, Libelt B, Morris A, Kramer NC, Prewitt TE, Bowen P, et al. Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochimica et Biophysica Acta 1992;1180(2):147-62.
72. Lee SP, Dart AM, Walker KZ, O'Dea K, Chin-Dusting JP, Skilton MR. Effect of altering dietary n-6:n-3 PUFA ratio on cardiovascular risk measures in patients treated with statins: a pilot study. British Journal of Nutrition 2012;108(7):1280-5.
73. Legrand P, Schmitt B, Mourot J, Catheline D, Chesneau G, Mireaux M, et al. The consumption of food products from linseed-fed animals maintains erythrocyte omega-3 fatty acids in obese humans. Lipids 2010;45(1):11-9.
74. Bemelmans WJ, Broer J, Feskens EJ, Smit AJ, Muskiet FA, Lefrandt JD, et al. Effect of an increased intake of α-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-linolenic Enriched Groningen Dietary Intervention (MARGARIN) study. American Journal of Clinical Nutrition 2002;75(2):221-7.
75. Bemelmans WJ, Broer J, de Vries JH, Hulshof KF, May JF, Meyboom-de Jong B. Impact of Mediterramean diet education versus posted leaflet on dietary habits and serum cholesterol in a high risk population for cardiovascular disease. Public Health Nutrition 2000;3(3):273-83.
76. Margolin G, Huster G, Glueck CJ, Speirs J, Vandegrift J, Illig E. Blood-pressure lowering in the elderly - a double-blind crossover study of omega-3 and omega-6 fatty-acids. American Journal of Clinical Nutrition 1990;51(3):518.
77. Margolin G, Huster G, Glueck CJ, Speirs J, Vandegrift J, Illig E, et al. Blood pressure lowering in elderly subjects: a double-blind crossover study of omega-3 and omega-6 fatty acids. American Journal of Clinical Nutrition 1991;53(2):562-72.
78. McDaniel JC, Ahijevych K, Belury M. Effect of n-3 oral supplements on the n-6/n-3 ratio in young adults. Western Journal of Nursing Research 2010;32(1):64-80.
79. Mendis S, Samarajeewa U, Thattil RO. Coconut fat and serum lipoproteins: effects of partial replacement with unsaturated fats. British Journal of Nutrition 2001;85(5):583-9.
80. Miles EA, Banerjee T, Calder PC. The influence of different combinations of gamma-linolenic, stearidonic and eicosapentaenoic acids on the fatty acid composition of blood lipids and mononuclear cells in human volunteers. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2004;70(6):529-38.
81. Mills DE, Prkachin KM, Harvey KA, Ward RP. Dietary fatty acid supplementation alters stress reactivity and performance in man. Journal of Human Hypertension 1989;3(2):111-6.
82. Minihane AM, Brady LM, Lovegrove SS, Lesauvage SV, Williams CM, Lovegrove JA. Lack of effect of dietary n-6:n-3 PUFA ratio on plasma lipids and markers of insulin responses in Indian Asians living in the UK. European Journal of Nutrition 2005;44(1):26-32.
83. Misikangas M, Freese R, Turpeinen AM, Mutanen M. High linoleic acid, low vegetable, and high oleic acid, high vegetable diets affect platelet activation similarly in healthy women and men. Journal of Nutrition 2001;131(6):1700-5.
84. Mortensen JZ, Schmidt EB, Nielsen AH, Dyerberg J. The effect of N-6 and N-3 polyunsaturated fatty acids on hemostasis, blood lipids and blood pressure. Thrombosis and Haemostasis 1983;50(2):543-6.
85. Møller J, Svaneborg N, Lervang HH, Varming K, Madsen P, Dyerberg J, et al. The acute effect of a single very high dose of N-3 fatty acids on coagulation and fibrinolysis. Thrombosis Research 1992;67(5):569-77.
86. Naber FB, Oudkerk Pool M, Teerlink T, Popp-Snijders C, Gans RO, Bilo HJ. Effect of short-term use of omega-3-type polyunsaturated fatty acids in subjects with hypertriglyceridemia [Dutch]. Nederlands Tijdschrift voor Geneeskunde 1992;136(31):1511-4.
87. Naumann E, Carpentier YA, Saebo A, Lassel TS, Chardigny JM, Sébédio JM, et al. Cis-9, trans- 11 and trans-10, cis-12 conjugated linoleic acid (CLA) do not affect the plasma lipoprotein profile in moderately overweight subjects with LDL phenotype B. Atherosclerosis 2006;188(1):167-74.
88. Nelson GJ, Schmidt PC, Bartolini G, Kelley DS, Phinney SD, Kyle D, et al. The effect of dietary arachidonic acid on plasma lipoprotein distributions, apoproteins, blood lipid levels, and tissue fatty acid composition in humans. Lipids 1997;32(4):427-33.
89. Nelson GJ, Kelley DS, Emken EA, Phinney SD, Kyle D, Ferretti A. A human dietary arachidonic acid supplementation study conducted in a metabolic research unit: rationale and design. Lipids 1997;32(4):415-20.
90. Nestel P, Noakes M, Belling GB, McArthur R, Clifton RM, Abbey M. Plasma cholesterol-lowering potential of edible-oil blends suitable for commercial use. American Journal of Clinical Nutrition 1992;55(1):46-50.
91. Nestel PJ, Noakes M, Belling GB, McArthur R, Clifton PM. Effect on plasma lipids of interesterifying a mix of edible oils. American Journal of Clinical Nutrition 1995;62(5):950-5.
92. Noakes M, Nestel P, Clifton P. Commercial frying fats and plasma lipid-lowering potential. Australian Journal of Nutrition and Dietetics 1996;53(1):25-30.
93. Oe H, Hozumi T, Murata E, Matsuura H, Negishi K, Matsumura Y, et al. Arachidonic acid and docosahexaenoic acid supplementation increases coronary flow velocity reserve in Japanese elderly individuals. Heart 2008;94(3):316-21.
94. Paschos GK, Zampelas A, Panagiotakos DB, Katsiougiannis S, Griffin BA, Votteas V, et al. Effects of flaxseed oil supplementation on plasma adiponectin levels in dyslipidemic men. European Journal of Nutrition 2007;46(6):315-20.
95. Pałkowska E, Bartnikowska E, Owsiak D. The use of low-caloric diet with modified fatty acids pool in the therapy of the metabolic syndrome. Roczniki Państwowego Zakładu Higieny 2012;63(2):163-9.
96. Perez-Martinez P, Garcia-Quintana J, Yubero-Serrano E, Tasset-Cuevas I, Tunez I, Garcia-Rios A, et al. Postprandial oxidative stress is modified by dietary fat: evidence from a human intervention study. Clinical Science 2010;119(6):251-61.
97. Perkins R, Wright IS, Gatje BW. Effect of safflower oil emulsion on serum cholesterol levels in young adult males. Its use as a supplement to a normal diet. Journal of the American Medical Association 1958;166(17):2132-5.
98. Radack K, Deck C, Huster G. The comparative effects of n-3 and n-6 polyunsaturated fatty acids on plasma fibrinogen levels: a controlled clinical trial in hypertriglyceridemic subjects. Journal of the American College of Nutrition 1990;9(4):352-7.
99. Radack K, Deck C, Huster G. The effects of low doses of n-3 fatty acid supplementation on blood pressure in hypertensive subjects. A randomized controlled trial. Archives of Internal Medicine 1991;151(6):1173-80.
100. Rajaram S, Sabate J, Mohan S. Effect of n-3 polyunsaturated fatty acids on peroxisome proliferator-activated receptor gamma (PPARγ) expression in adults. FASEB Journal. 2012; Vol. 26:823.28.
101. Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A. Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 2003;167(2):237-42.
102. Rallidis LS, Paschos G, Papaioannou M, Liakos GK, Panagiotakos DB, Anastasiadis G, et al. The effect of diet enriched with alpha-linolenic acid on soluble cellular adhesion molecules in dyslipidaemic patients. Atherosclerosis 2004;174(1):127-32.
103. Ramprasath VR, Jones PJ, Buckley DD, Woollett LA, Heubi JE. Decreased plasma cholesterol concentrations after PUFA-rich diets are not due to reduced cholesterol absorption/synthesis. Lipids 2012;47(11):1063-71.
104. Reaven P, Parthasarathy S, Grasse BJ, Miller E, Almazan F, Mattson FH, et al. Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans. American Journal of Clinical Nutrition 1991;54(4):701-6.
105. Risérus U, Basu S, Jovinge S, Fredrikson G, Arnlöv J, Vessby B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 2002;106(15):1925-9.
106. Risérus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002;25(9):1516-21.
107. Risérus U, Vessby B, Arner P, Zethelius B. Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia 2004;47(6):1016-9.
108. Robertson MD, Jackson KG, Fielding BA, Morgan LM, Williams CM, Frayn KN. Acute ingestion of a meal rich in n-3 polyunsaturated fatty acids results in rapid gastric emptying in humans. American Journal of Clinical Nutrition 2002;76(1):232-8.
109. Roche H, Ferguson JF, Perez-Martinez P, Lovegrove JA, Drevon CA, Defoort C, et al. Dietary fats, inflammation and insulin resistance-insights from the lipgene study. Atherosclerosis Supplements 2009;10:2.
110. Sanders TA, Hochland MC. A comparison of the influence on plasma lipids and platelet function of supplements of omega 3 and omega 6 polyunsaturated fatty acids. British Journal of Nutrition 1983;50(3):521-9.
111. Sanders TA, Oakley FR, Miller GJ, Mitropoulos KA, Crook D, Oliver MF. Influence of n-6 versus n-3 polyunsaturated fatty acids in diets low in saturated fatty acids on plasma lipoproteins and hemostatic factors. Arteriosclerosis, Thrombosis, and Vascular Biology 1997;17(12):3449-60.
112. Singer P, Wirth M, Kretschmer H. Different changes of n-6 fatty acids in lipoproteins from hyperlipemic subjects after diets supplemented with n-3 fatty acids. Prostaglandins, Leukotrienes, and Essential Fatty Acids 1991;42(2):107-11.
113. Sirtori CR, Gatti E, Tremoli E, Galli C, Gianfranceschi G, Franceschini G, et al. Olive oil, corn oil, and n-3 fatty acids differently affect lipids, lipoproteins, platelets, and superoxide formation in type II hypercholesterolemia. American Journal of Clinical Nutrition 1992;56(1):113-22.
114. Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans--metabolic effects. Lipids 2001;36(8):773-81.
115. Sofi F, Buccioni A, Cesari F, Gori A, Minieri S, Mannini L, et al. Effects of a dairy product (pecorino cheese) naturally rich in cis-9, trans-11 conjugated linoleic acid on lipid, inflammatory and haemorheological variables: a dietary intervention study. Nutrition, Metabolism, and Cardiovascular Diseases 2010;20(2):117-24.
116. Sofi F, Giorgi G, Cesari G, Gori AM, Mannini L, Parisi G, et al. The atherosclerotic risk profile is affected differently by fish flesh with a similar EPA and DHA content but different n-6/n-3 ratio. Asia Pacific Journal of Clinical Nutrition 2013;22(1):32-40.
117. Solà R, La Ville AE, Richard JL, Motta C, Bargalló MT, Girona J, et al. Oleic acid rich diet protects against the oxidative modification of high density lipoprotein. Free Radical Biology & Medicine 1997;22(6):1037-45.
118. Song HJ, Grant I, Rotondo D, Mohede I, Sattar N, Heys SD, et al. Effect of CLA supplementation on immune function in young healthy volunteers. European Journal of Clinical Nutrition 2005;59(4):508-17.
119. Steck SE, Chalecki AM, Miller P, Conway J, Austin GL, Hardin JW, et al. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. Journal of Nutrition 2007;137(5):1188-93.
120. Sundram K, Hornstra G, von Houwelingen AC, Kester AD. Replacement of dietary fat with palm oil: effect on human serum lipids, lipoproteins and apolipoproteins. British Journal of Nutrition 1992;68(3):677-92.
121. Svaneborg N, Møller JM, Schmidt EB, Varming K, Lervang HH, Dyerberg J. The acute effects of a single very high dose of n-3 fatty acids on plasma lipids and lipoproteins in healthy subjects. Lipids 1994;29(2):145-7.
122. Tavakkoli D, Hosseinpanah F, Tahbaz F, Amiri Z, Tavakkoli D, Hedayati M. Effects of conjugated linoleic acid supplementation on body composition and leptin concentration in post-menopausal women [Arabic]. Iranian Journal of Endocrinology and Metabolism 2010;12(1):48-59, 84.
123. Taylor JS, Williams SR, Rhys R, James P, Frenneaux MP. Conjugated linoleic acid impairs endothelial function. Arteriosclerosis, Thrombosis, and Vascular Biology 2006;26(2):307-12.
124. Tholstrup T, Raff M, Straarup EM, Lund P, Basu S, Bruun JM. An oil mixture with trans-10, cis-12 conjugated linoleic acid increases markers of inflammation and in vivo lipid peroxidation compared with cis-9, trans-11 conjugated linoleic acid in postmenopausal women. Journal of Nutrition 2008;138(8):1445-51.
125. Tierney AC, McMonagle J, Shaw DI, Gulseth HL, Helal O, Saris WH, et al. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome--LIPGENE: a European randomized dietary intervention study. International Journal of Obesity 2011;35(6):800-9.
126. Truswell AS. Comparing palmolein with different predominantly monounsaturated oils: effect on plasma lipids. International Journal of Food Sciences and Nutrition 2000;15 Suppl:S73-7.
127. Tsai PJ, Lu SC. Fish oil lowers plasma lipid concentrations and increases the susceptibility of low density lipoprotein to oxidative modification in healthy men. Journal of the Formosan Medical Association 1997;96(9):718-26.
128. Tsofliou F, Fyfe C, Matheson I, Jackson D, Horgan G, Wahle K, et al. Fasted and postprandial plasma lipids in healthy volunteers by a dietary mixture of omega-3 fatty acid modulation and conjugated linoleic acid. Journal of Food Lipids 2009;16:499-513.
129. Tulk HM, Robinson LE. Modifying the n-6/n-3 polyunsaturated fatty acid ratio of a high-saturated fat challenge does not acutely attenuate postprandial changes in inflammatory markers in men with metabolic syndrome. Metabolism: Clinical and Experimental 2009;58(12):1709-16.
130. Valsta LM, Salminen I, Aro A, Mutanen M. Alpha-linolenic acid in rapeseed oil partly compensates for the effect of fish restriction on plasma long chain n-3 fatty acids. European Journal of Clinical Nutrition 1996;50(4):229-35.
131. Venter CP, Joubert PH, Booyens J. Effects of essential fatty acids on mild to moderate essential hypertension. Prostaglandins, Leukotrienes, and Essential Fatty Acids 1988;33(1):49-51.
132. Vergroesen AJ, de Deckere EA, ten Hoor F, Hornstra G. Cardiovascular effects of linoleic acid. Progress in Food & Nutrition Science 1980;4(5):13-25.
133. Vericel E, Lagarde M, Mendy F. Comparative effects of linoleic acid and gamma-linolenic acid intake on plasma lipids and platelet phospholipids in elderly people. Nutrition Research 1987;7:569-80.
134. Vermunt SH, Beaufrère B, Riemersma RA, Sébédio JL, Chardigny JM, Mensink RP, et al. Dietary trans alpha-linolenic acid from deodorised rapeseed oil and plasma lipids and lipoproteins in healthy men: the TransLinE Study. British Journal of Nutrition 2001;85(3):387-92.
135. Viikari J, Lehtonen A. Effect of primrose oil on serum lipids and blood pressure in hyperlipidemic subjects. International Journal of Clinical Pharmacology, Therapy, and Toxicology 1986;24(12):668-70.
136. West SG, Krick AL, Klein LC, Zhao G, Wojtowicz TF, McGuiness M, et al. Effects of diets high in walnuts and flax oil on hemodynamic responses to stress and vascular endothelial function. Journal of the American College of Nutrition 2010;29(6):595-603.
137. Wilkinson P, Leach C, Ah-Sing EE, Hussain N, Miller GJ, Millward DJ, et al. Influence of alpha-linolenic acid and fish-oil on markers of cardiovascular risk in subjects with an atherogenic lipoprotein phenotype. Atherosclerosis 2005;181(1):115-24.
138. Yam D, Bott-Kanner G, Genin I, Shinitzky M, Klainman E. The effect of omega-3 fatty acids on risk factors for cardiovascular diseases [Hebrew]. Harefuah 2001;140(12):1156-8, 1230.
139. Zhao G, Etherton TD, Martin KR, West SG, Gillies PJ, Kris-Etherton PM. Dietary a-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. Journal of Nutrition 2004;134(11):2991-7.
140. Zhao G, Etherton TD, Martin KR, Gillies PJ, West SG, Kris-Etherton PM. Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. American Journal of Clinical Nutrition 2007;85(2):385-91.
141. Natvig H. The effect of unsaturated fatty acids on the incidence of coronary infarction [Effekten av umettede fettsyrer pa hyppigheten av hjerteinfarkt m.m. Resultatet av bedrifslegenes 'oljeforsok']. Tidsskrift for den Norske lægeforening 1967;87(11):1033-41.
142. Natvig H. The effect of unsaturated fatty acids on the incidence of coronary infarction [Effekten av umettede fettsyrer pa hyppigheten av hjerteinfarkt m.m. Resultatet av bedrifslegenes 'oljeforsok']. Tidsskrift for den Norske lægeforening 1967;87(11):1033-41.
143. Nordoy A, Brox JH, Killie JE. Influence of cod liver oil and corn oil on platelets and vessel wall in man [abstract]. Thrombosis and Haemostasis 1981;46(1):178.
144. Ryu S, Fisher J, Snook J. Polyunsaturated fatty acid (PUFA) intake in the development of heart disease in participants in the lipid research clinics coronary primary prevention trial (LRC-CPPT). FASEB Journal 1999;13:A933.
145. Singer P. Different changes of N-6 fatty acids in lipoproteins from hyperlipaemic subjects after diets supplemented with N-3 fatty acids [German]. Aktuelle Ernährungsmedizin Klinik und Praxis 1993;18:368-72.
146. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A. The burden of disease and injury in Australia 2003. www.aihw.gov.au/publication-detail/?id=6442467990 (accessed 24 April 2014).
147. British Heart Foundation. Cardiovascular disease. www.bhf.org.uk/heart-health/conditions/cardiovascular-disease.aspx (accessed 24 April 2014).
148. Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?. British Journal of Clinical Pharmacology 2013;75(3):645-62.
149. Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Annals of Internal Medicine 2014;160(6):398-406.
150. Esrey KL, Joseph L, Grover SA. Relationship between dietary intake and coronary heart disease mortality: lipid research clinics prevalence follow-up study. Journal of Clinical Epidemiology 1996;49(2):211-6.
151. Farvid MS, Ding M, Pan A, Sun Q, Chiuve SE, Steffen LM, et al. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation 2014;130(18):1568-78.
152. Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. Journal of Clinical Epidemiology 1992;45(7):769-73.
153. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low- and middle-income countries. Current Problems in Cardiology 2010;35(2):72-115.
154. Groff JL, Gropper SS, Hunt SM. Advanced Nutrition and Human Metabolism. 2nd Edition. New York: Wandsworth Publishing, 1995.
155. Hall WL. Dietary saturated and unsaturated fats as determinants of blood pressure and vascular function. Nutrition Research Reviews 2009;22(1):18-38.
156. Harris WS, Poston WC, Haddock CK. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 2007;193(1):1-10.
157. Harris W. Omega-6 and omega-3 fatty acids: partners in prevention. Current Opinion in Clinical Nutrition and Metabolic Care 2010;13(2):125-9.
158. Hartley L, Clar C, Flowers N, Hooper L, Rees K. Omega 6 fatty acids for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2014, Issue 5. [DOI: 10.1002/14651858.CD011094]
159. He K, Merchant A, Rimm EB, Rosner BA, Stampfer MJ, Willett WC, et al. Dietary fat intake and risk of stroke in male US healthcare professionals: 14 year prospective cohort study. BMJ 2003;327(7418):777-82.
160. He FJ, MacGregor GA. Reducing population salt intake worldwide: from evidence to implementation. Progress in Cardiovascular Diseases 2010;52(5):363-82.
161. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
162. Hooper L, Summerbell CD, Thompson R, Sills D, Roberts FG, Moore H, et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD002137.pub2]
163. Jakobsen MU, O'Reilly EJ, Heitmann BL, Pereira MA, Bälter K, Fraser GE, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. American Journal of Clinical Nutrition 2009;89(5):1425-32.
164. Katan MB. Omega-6 polyunsaturated fatty acids and coronary heart disease. American Journal of Clinical Nutrition 2009;89(5):1283-4.
165. Laaksonen DE, Nyyssönen K, Niskanen L, Rissanen TH, Salonen JT. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Archives of Internal Medicine 2005;165(2):193-9.
166. Law M, Wald N. Why heart disease mortality is low in France: the time lag explanation. BMJ 1999;318(7196):1471-6.
167. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
168. McGee DL, Reed DM, Yano K, Kagan A, Tillotson J. Ten-year incidence of coronary heart disease in the Honolulu Heart Program: relationship to nutrient intake. American Journal of Epidemiology 1984;119(5):667-76.
169. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. American Journal of Clinical Nutrition 2003;77(5):1146-55.
170. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Medicine 2010;7(3):e1000252.
171. Müller-Nordhorn J, Binting S, Roll S, Willich SN. An update on regional variation in cardiovascular mortality within Europe. European Heart Journal 2008;29(10):1316-26.
172. National Health Service. Atherosclerosis, 2012. www.nhs.uk/conditions/Atherosclerosis/Pages/Introduction.aspx#commentCountLink (accessed 24 April 2014).
173. Oh K, Hu FB, Manson JE, Stampfer MJ, Willett WC. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study. American Journal of Epidemiology 2005;161(7):672-9.
174. Pietinen P, Ascherio P, Korhonen P, Hartman A, Willett WC, Albanes D, et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. American Journal of Epidemiology 1997;145(10):876-87.
175. Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 2013;346:e8707.
176. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
177. Rincón-Cervera M, Rodríguez-García I, Guil-Guerrero J. Purification of GLA-triglycerides from evening primrose oil by gravimetric column chromatography. Journal of the American Oil Chemists' Society 2009;86(7):605-9.
178. Russo GL. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochemical Pharmacology 2009;77(6):937-46.
179. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. American Journal of Clinical Nutrition 2010;91(3):535-46.
180. Spagnoli L, Bonanno E, Sangiorgi G, Mauriello A. Role of inflammation in atherosclerosis. Journal of Nuclear Medicine 2007;48(11):1800-15.
181. Rett BS, Whelan J. Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: a systematic review. Nutrition & Metabolism 2011;8:36.
182. World Health Organization. Cardiovascular diseases (CVDs). Fact sheet number 317. www.who.int/mediacentre/factsheets/fs317/en/ (accessed 24 April 2014).